financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tornado Infrastructure Equipment Up 3% As Launches Financing Arm, Provides Q4 Business Update
Tornado Infrastructure Equipment Up 3% As Launches Financing Arm, Provides Q4 Business Update
Feb 4, 2025
10:58 AM EST, 02/04/2025 (MT Newswires) -- Tornado Global Hydrovacs (TGH.V), involved in the vacuum truck industry, was at last look up 3% on Tuesday after launching Tornado Equipment Finance, a dedicated financing arm to provide financing solutions to support to customers in Canada. The company in a statement said it expects the new initiative to generate a steady additional...
Global Water Files Settlement Deal in Farmers Water Rate Case
Global Water Files Settlement Deal in Farmers Water Rate Case
Feb 4, 2025
10:58 AM EST, 02/04/2025 (MT Newswires) -- Global Water Resources ( GWRS ) said Tuesday it has reached a unanimous settlement agreement over the general rate case application of its Global Water - Farmers Water Company unit. The company said the settlement agreement was filed with the Arizona Corporation Commission last month, with a hearing on the agreement scheduled to...
United Therapeutics Completes Patient Enrollment for Another Trial of Idiopathic Pulmonary Fibrosis Treatment
United Therapeutics Completes Patient Enrollment for Another Trial of Idiopathic Pulmonary Fibrosis Treatment
Feb 4, 2025
10:59 AM EST, 02/04/2025 (MT Newswires) -- United Therapeutics ( UTHR ) said Tuesday that a phase 3 study evaluating the use of nebulized Tyvaso to treat idiopathic pulmonary fibrosis, of IPF, has reached full enrollment. The 598-patient Teton 1 study is part of three-study clinical trial program assessing the use of inhaled treprostinil in IPF and a similar condition...
Inflection Point Acquisition, USA Rare Earth Receive Additional $15.3 Million PIPE Financing
Inflection Point Acquisition, USA Rare Earth Receive Additional $15.3 Million PIPE Financing
Feb 4, 2025
10:56 AM EST, 02/04/2025 (MT Newswires) -- Inflection Point Acquisition (IPXX) and USA Rare Earth said Tuesday they have received an additional $15.3 million in PIPE financing from Inflection Point's affiliates and other investors, in connection with their previously announced proposed business combination. This brings the total investment of Inflection Point's affiliates and other investors to roughly $30 million, according...
Copyright 2023-2026 - www.financetom.com All Rights Reserved